Curapressin 1 mg/5 ml, Injektionslösung

7680700300018 CH-70030 Injektionslösung

No image available

Article details

Package size
5 x 5 ml
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
21/04/2026
Summary of Product Characteristics
Français
21/04/2026
Summary of Product Characteristics
Italien
21/04/2026

Detailed composition

Substance Quantity Type Category
terlipressini acetas
1.0 MG Substance WIZUS
terlipressinum
0.85 MG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
natrium
17.85 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Curatis AG

4410 Liestal

Authorization information

Swissmedic authorization number
70030
Drug name
Curapressin, Injektionslösung
Galenic form
LSINJ
ATC Code
H01BA04
Authorization status
Z
Dispensing category
B
First authorization
23/12/2025
Authorization expiration date
22/12/2030
IT Number
06.02.0.
Domain
Human medicine
Field of application
Akutbehandlung blutender Ösophagusvarizen, Notfallbehandlung des hepatorenalen Syndroms (HRS) Typ I bei Erwachsenen

Package details

Description (FR)
Curapressin 1 mg/5 ml sol inj 5 pce
Description (DE)
Curapressin 1 mg/5 ml Inj Lös 5 Stk
Market launch
01/05/2026
Narcotic (BTM)
No

Other package sizes (1)

None
5 x 10 ml DUR
GTIN: None
Not in V1
Buy us a coffee Explore the data